Skip to content

Validity of Pain Threshold Index in Children

Validity of Pain Threshold Index Based on Electroencephalogram for Pediatric Patients Under General Anesthesia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03622242
Enrollment
180
Registered
2018-08-09
Start date
2018-08-13
Completion date
2019-07-31
Last updated
2018-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, General, Electroencephalography

Brief summary

Comparison of total infused dose of remifentanil between pain threshold index monitoring group and control group

Detailed description

Investigators plan to enroll pediatric patients aged between 3 and 12 years old undergoing surgery under general anesthesia with continuous infusion of 2% propofol and remifentanil. After dividing them into two groups, investigators monitor pain threshold index and wavelet index in test group and adjust remifentanil infusion to maintain both indices in desirable range, while monitoring only wavelet index and adjust remifentanil infusion to maintain wavelet index and conventional vital signs in desirable range in control group. Investigators compare consumption of remifentanil, time to extubation after surgery, and post-anesthesia care unit length of stay between both groups.

Interventions

DEVICEPain threshold index

In pain threshold index monitor, monitor patients' pain threshold index based on electroencephalography and adjust infusion rate of remifentanil and propofol according to pain threshold index

DEVICEWavelet index

In wavelet index monitor, monitor patients' wavelet index based on electroencephalography as an indicator of depth of anesthesia and adjust infusion rate of propofol according to wavelet index

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children between 3 and 12 years old undergoing orthopedic surgery at extremities under general anesthesia

Exclusion criteria

* History of adverse drug reactions to opioids * Underlying neurological disease or taking medication for neurologic purpose * Patients who were transferred to intensive care unit after the surgery

Design outcomes

Primary

MeasureTime frameDescription
Remifentanil consumptionAt the end of anesthesia, total anesthesia time less than 1 dayTotal amount of infused remifentanil divided by patient's weight and total anesthesia time

Secondary

MeasureTime frameDescription
Extubation timeAt the end of anesthesia, less than 1 hourElapsed time from end of surgery to extubation
Post-anesthesia care unit length of stayAt discharge from post-anesthesia care unit, less than 1 dayLength of stay at post-anesthesia care unit

Countries

South Korea

Contacts

Primary ContactSang-Hwan Ji, M.D., M.S.
taepoongshin@gmail.com+82-10-9251-5019
Backup ContactYoung-Eun Jang, M.D., M.S.
na0ag2@hotmail.com+82-10-9487-2233

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026